Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBD Med Research Corp. was a Canadian public company that transitioned from natural resource exploration to the life sciences and medical cannabis sectors. In February 2019, the company completed a reverse takeover (RTO) with World Class Extractions Inc., a developer of innovative, industrial-scale extraction processes for the hemp and cannabis industries. The resulting entity, World Class Extractions, focused on providing single-step continuous flow extraction services to produce high-quality CBD oil and other cannabinoid extracts. The company's technology was designed to offer higher yields and better quality crude oil at faster rates compared to traditional methods. In 2023, the successor company rebranded as Stock Trend Capital Inc., shifting its strategic focus toward investment in high-growth sectors such as AI and cryptocurrency while maintaining interests in life sciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBD Med Research.